The Vacuum Pharmaceutical Drying Machine segmentation by application reflects the therapeutic form that drives equipment demand. Oral solids—including tablets, capsules, and granules—represent the largest share, accounting for roughly 45 % of total market value, because bulk processing and stringent moisture‑control requirements dominate this segment. Injectables occupy about 30 % as sterile liquid formulations require low‑temperature vacuum drying to preserve bio‑activity and prevent microbial growth. Biologics, encompassing proteins, antibodies, and vaccines, contribute 15 %; their sensitivity to heat and oxidation makes vacuum drying the preferred method for maintaining structural integrity. The residual Other category (10 %) captures niche uses such as ophthalmic solutions, inhalation powders, and veterinary products, each demanding specialized drying cycles. Collectively, these application sub‑segments define the market’s revenue distribution, with each contributing proportionally to equipment capacity planning, technology adoption, and R&D investment across the vacuum drying ecosystem.